Systemic effects of epidural steroid injections for spinal stenosis.

Originally published in PAIN Journal 2018; 159: 876-83. Translation: Ariel Francis.

Authors

  • Janna L. Friedly Centro de Investigación de costos, efectividad y evolución, comparativos de la Universidad de Washington, Seatle, WA, USA.
  • Bryan A. Comstock Centro de Investigación de costos, efectividad y evolución, comparativos de la Universidad de Washington, Seatle, WA, USA.
  • Patrick J. Heagerty Centro de Investigación de costos, efectividad y evolución, comparativos de la Universidad de Washington, Seatle, WA, USA.
  • Zoya Bauera Centro de Investigación de costos, efectividad y evolución, comparativos de la Universidad de Washington, Seatle, WA, USA.
  • Micol S. Rothman Departamento de Medicina, Universidad de Colorado, Aurora, CO, USA.
  • Pradeep Suri Departamento de Terapias Física y de Rehabilitación. Universidad de Colorado, Aurora, CO, USA.
  • Ryan Hanen Departamento de Farmacia, de la Universidad de Washington, Seatle, WA, USA.
  • Andrew L. Avins Centro permanente de investigación en Salud Kaiser, Portland Oregon, USA.
  • Srdjan S. Nedeljkovic Centro permanente de investigación en Salud Kaiser, Portland Oregon, USA.
  • David R. Nerenz Radiología de la Universidad de Washington, Seatle, WA, USA.
  • Venu Akuthota Radiología de la Universidad de Washington, Seatle, WA, USA.
  • Jeffrey G. Jarvik Radiología de la Universidad de Washington, Seatle, WA, USA.

DOI:

https://doi.org/10.47924/neurotarget2018127

Keywords:

Lumbar spinal stenosis, Corticosteroid, Epidural steroid injection, Back pain, Cortisol suppression, Systemic effects

Abstract

This analysis of the lumbar epidural steroid injections for spinal stenosis multicenter randomized controlled trial data identifies thedegree of and risk factors for cortisol suppression after epidural steroid injections in older adults with spinal stenosis. Four hundredpatients aged 50 years and older with back or leg pain and central lumbar spinal stenosis completed baseline demographic andpsychosocial measures. Morning serum cortisol levels were measured at baseline and 3 weeks after initial injection. Patients were
randomized to receive epidural injections of either local anesthetic with corticosteroid (n 5 200) or local anesthetic only (n 5 200).The specific corticosteroid was chosen at the treating physician’s discretion (methylprednisolone, betamethasone, triamcinolone, ordexamethasone). Thirty-two patients (20.3%) treated with corticosteroid experienced cortisol reduction at 3 weeks of .50%compared with 10 patients (6.7%) treated with lidocaine only (adjusted treatment effect53.5, 95% confidence interval: 1.6-7.9, P5
0.002). The effect on 3-week cortisol changes did not differ by demographic or patient-level characteristics. Those treated withmethylprednisolone or triamcinolone had an average 3-week cortisol reduction of 41.0% (P 5 0.005) and 41.6% (P , 0.001) frombaseline, respectively, whereas patients treated with betamethasone or dexamethasone were not significantly different thancomparable patients in the lidocaine arm. The higher rates of cortisol suppression at 3 weeks in those receiving epiduralcorticosteroid injections, particularly with longer-acting insoluble corticosteroid formulations, are consistent with sustained systemicabsorption of corticosteroid.

Metrics

Metrics Loading ...

References

Boden S. The use of radiographic imaging studies in the evaluation of patients who have degenerative disorders of the lumbar spine. J Bone Joint Surg am 1996; 78: 114-24.

Burn JM, Langdon L. Duration of action of epidural methyl prednisolone. A study in patients with the lumbosciatic syndrome. Am J Phys Med 1974; 53: 29–34.

Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet 2014; 383: 2152–67.

Dubois EF, Wagemans MF, Verdouw BC, Zwinderman AH, Van Boxtel CJ, Dekhuijzen PN, Schweitzer DH. Lack of relationships between cumulative methylprednisolone dose and bone mineral density in healthy men and postmenopausal women with chronic low back pain. Clin Rheumatol 2003; 22: 12–7.

Friedly J, Bresnahan B, Comstock B, Turner J, Deyo R, Sullivan S, Heagerty P, Bauer Z, Nedeljkovic S, Avins A, Nerenz D, Jarvik J. Study protocol- lumbar epidural steroid injections for spinal stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults. BMC Musculoskelet Disord 2012; 13: 48.

Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, Mandel S, Tyburski M, Sanders W, Sibell D, Smuck M, Wasan A, Won L, Jarvik JG. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med 2014; 371: 11–21.

Grierson MJ, Harrast MA. Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIVinfected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists. PM R 2012; 4: 234–7.

Horani MH, Silverberg AB. Secondary Cushing’s syndrome after a single epidural injection of a corticosteroid. Endocr Pract 2005; 11: 408–10.

Jacobs S, Pullan PT, Potter JM, Shenfield GM. Adrenal suppression following extradural steroids. Anaesthesia 1983; 38: 953–6.

Johnston PC, Lansang MC, Chatterjee S, Kennedy L. Intraarticular glucocorticoid injections and their effect on hypothalamicpituitaryadrenal (HPA)-axis function. Endocrine 2015; 48: 410–6.

Kay J, Findling JW, Raff H. Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth Analg 1994; 79: 501–5.

Lansang MC, Farmer T, Kennedy L. Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr Pract 2009; 15: 225–8.

Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika, 1986. p. 13–22.

Maillefert JF, Aho S, Piroth-Chatard C, Tavernier C. Cortisol levels after single local steroid injection. Am J Med 1996; 100: 586–7.

Manson SC, Brown RE, Cerulli A, Vidaurre CF. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 2009; 103: 975–94.

Olivarius Nde F, Siersma V, Dyring-Andersen B, Drivsholm T, Hansen LJ, Henriksen JE. Patients newly diagnosed with clinical type 2 diabetes during oral glucocorticoid treatment and observed for 14 years: all-cause mortality and clinical developments. Basic Clin Pharmacol Toxicol 2011; 108: 285–8.

R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2012. ISBN 3-900051-07-0. Available at: http://www.r-project. org/.

R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013.

Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008; 47: 97–9.

Roland M, Morris R. A study of the natural history of back pain. Part 1: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 1983; 8: 141–4.

Published

2018-07-01

How to Cite

1.
Friedly JL, Comstock BA, Heagerty PJ, Bauera Z, Rothman MS, Suri P, et al. Systemic effects of epidural steroid injections for spinal stenosis.: Originally published in PAIN Journal 2018; 159: 876-83. Translation: Ariel Francis. NeuroTarget [Internet]. 2018 Jul. 1 [cited 2024 Dec. 4];12(2):40-9. Available from: https://neurotarget.com/index.php/nt/article/view/127

Issue

Section

Special Papers